Idiopathic Pulmonary Fibrosis

Latest News in Idiopathic Pulmonary Fibrosis

March 13, 2025

Identification and validation of biomarkers related to ferroptosis in idiopathic pulmonary fibrosis – Nature

March 7, 2025

One in Five Idiopathic Pulmonary Fibrosis Deaths May Be Due to Occupational Exposures – HealthDay

March 3, 2025

(PDF) Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland – ResearchGate

March 3, 2025

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis – GlobeNewswire

March 3, 2025

Targeted therapy for idiopathic pulmonary fibrosis: a bibliometric analysis of 2004–2024 – Frontiers

108 Active Idiopathic Pulmonary Fibrosis Clinical Trials

As of April 1, 2025

Source: clinicaltrials.gov

LOCATE

CLINICAL TRIALS

BROWSE

FDA-approved DRUGS

WHAT IS

CONGRESS DOING?